Cough Clinical Trial
Official title:
The Efficacy of Intravenous Lidocaine With Continuous Infusion of Remifentanil for Attenuating Double Lumen Tube Induced Cough During Emergence
Cough suppression during emergence and tracheal extubation from general anaesthesia has
become an important issue as part of patient safety. Cough arised from the mechanical
irritation of endotracheal tube and cuff could be accompanied by various adverse effects such
as laryngospasm, hypertension, tachycardia, arrhythmia and increase of intracranial,
intraocular, or intra-abdominal pressure.
Several cough-preventing strategies have been proposed for smooth emergence, such as opioids,
dexmedetomidine or lidocaine. Maintenance of remifentanil infusion during emergence has been
reported to be an effective method in reducing cough and cardiovascular change without delay
of recovery. In previous studies, the effetive effect-site concentraions for 95% of adults
(EC95) for preventing cough are a little different depending on anaestheic agent, type of
surgery and sex, ranged from 2.14 to 2.94 ng/ml. However, since most of these studies are for
sing lumen endotracheal tube, similar preventing effect would not be expected for double
lumen tube (DLT) because of its large diameter and long length. Another problem is higher
concentration of remifentanil more than 2.5 ng/ml could not guarantee the safety after
extubation. The efficacy of a single IV bolus of lidocaine for the prevention of cough has
been the subject of numerous trials.
Therefore, combined use of lidocaine and remifentanil could effectively prevent emergence
cough for DLT without the risk of high concentration of remifentanil.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00116337 -
Spinal Cord Stimulation to Restore Cough
|
N/A | |
| Not yet recruiting |
NCT04064333 -
Slow-Stream Expiratory Muscle Strength Training for Veterans With Dysphagia Living in Long-term Care
|
N/A | |
| Recruiting |
NCT02482818 -
Efficacy of Pregabalin on Chronic Cough
|
Phase 1/Phase 2 | |
| Terminated |
NCT02269761 -
Chest Ultrasound of ER Patients With Cough or SOB
|
||
| Active, not recruiting |
NCT02065440 -
The Effect of Ebastine/Pseudoephedrine on Subacute Cough
|
N/A | |
| Completed |
NCT01071161 -
The Effect of Azithromycin in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Productive Cough
|
Phase 3 | |
| Completed |
NCT00353951 -
An Observational Study of Cough / Lower Respiratory Tract Infection (LRTI) in Primary Care
|
N/A | |
| Terminated |
NCT00668317 -
Bronchial Hyper-responsiveness in Reflux Cough
|
Phase 3 | |
| Completed |
NCT00127686 -
Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep
|
Phase 1 | |
| Completed |
NCT00287339 -
The Utility of Nexium in Chronic Cough and Reflux Disease
|
Phase 4 | |
| Recruiting |
NCT05115097 -
AI Evaluation of COVID-19 Sounds (AI-EChOS)
|
||
| Recruiting |
NCT04457011 -
Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children
|
Phase 2 | |
| Recruiting |
NCT05042063 -
Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease
|
||
| Recruiting |
NCT03922373 -
A Study of Benzonatate Soft Capsule in Chinese Healthy Subjects
|
Phase 1 | |
| Completed |
NCT05812209 -
Stellate Ganglion Block to Treat Long COVID 19 Case Series
|
||
| Recruiting |
NCT04767074 -
A Non-pharmacological Cough Control Therapy
|
N/A | |
| Recruiting |
NCT05570539 -
Assessment of the Pharmacokinetics of BLU-5937 Extended Release Prototypes and a BLU-5937 Immediate Release Reference Formulation
|
Phase 1 | |
| Completed |
NCT03999203 -
A Cross-sectional Study to Measure Cough in Severe Asthma
|
N/A | |
| Active, not recruiting |
NCT05479929 -
Work of Breathing Assessment in Triage Scale
|
||
| Recruiting |
NCT02495571 -
Assessment of Voluntary and Reflex Cough in Patients With ALS
|
N/A |